Cargando…
Detection of circulating tumor DNA in patients with osteosarcoma
Identification and quantification of somatic alterations in plasma-derived, circulating tumor DNA (ctDNA) is gaining traction as a non-invasive and cost effective method of disease monitoring in cancer patients, particularly to evaluate response to treatment and monitor for disease recurrence. To ou...
Autores principales: | Barris, David M., Weiner, Shoshana B., Dubin, Robert A., Fremed, Michael, Zhang, Xusheng, Piperdi, Sajida, Zhang, Wendong, Maqbool, Shahina, Gill, Jonathan, Roth, Michael, Hoang, Bang, Geller, David, Gorlick, Richard, Weiser, Daniel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849166/ https://www.ncbi.nlm.nih.gov/pubmed/29560102 http://dx.doi.org/10.18632/oncotarget.24268 |
Ejemplares similares
-
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
por: Koirala, Pratistha, et al.
Publicado: (2016) -
The effect of bone morphogenetic protein-2 on osteosarcoma metastasis
por: Gill, Jonathan, et al.
Publicado: (2017) -
Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma
por: Poon, Vincent I, et al.
Publicado: (2015) -
Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model
por: Yang, Yi, et al.
Publicado: (2017) -
HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival
por: Koirala, Pratistha, et al.
Publicado: (2016)